MIDDLETON, Wis.--(BUSINESS WIRE)--Imbed Biosciences (“Imbed”), a pioneer in breakthrough wound care synthetic matrix technology, today announced the U.S. Food and Drug Administration (FDA) has ...

The addition to its KVM matrix portfolio brings enterprise-grade KVM capabilities to more streamlined applications with a ‘plug and play’ architecture When you purchase through links on our site, we ...